165 related articles for article (PubMed ID: 8806513)
1. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells.
Boppana SB; Britt WJ
Virology; 1996 Aug; 222(1):293-6. PubMed ID: 8806513
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
Gyulai Z; Endresz V; Burian K; Pincus S; Toldy J; Cox WI; Meric C; Plotkin S; Gönczöl E; Berencsi K
J Infect Dis; 2000 May; 181(5):1537-46. PubMed ID: 10823751
[TBL] [Abstract][Full Text] [Related]
3. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
4. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
[TBL] [Abstract][Full Text] [Related]
5. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity.
Borysiewicz LK; Morris S; Page JD; Sissons JG
Eur J Immunol; 1983 Oct; 13(10):804-9. PubMed ID: 6196203
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-specific cytolytic T-cell lines and clones generated against adenovirus-pp65-infected dendritic cells.
Keever-Taylor CA; Margolis D; Konings S; Sandford GR; Nicolette CA; Lawendowski C; Burns WH
Biol Blood Marrow Transplant; 2001; 7(5):247-56. PubMed ID: 11400946
[TBL] [Abstract][Full Text] [Related]
8. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
Cho HI; Han H; Kim CC; Kim TG
J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
Elkington R; Shoukry NH; Walker S; Crough T; Fazou C; Kaur A; Walker CM; Khanna R
Eur J Immunol; 2004 Nov; 34(11):3216-26. PubMed ID: 15368271
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity.
Borysiewicz LK; Graham S; Hickling JK; Mason PD; Sissons JG
Eur J Immunol; 1988 Feb; 18(2):269-75. PubMed ID: 2832181
[TBL] [Abstract][Full Text] [Related]
11. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.
Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S
J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198
[TBL] [Abstract][Full Text] [Related]
12. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods.
Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G
Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B.
Hopkins JI; Fiander AN; Evans AS; Delchambre M; Gheysen D; Borysiewicz LK
J Med Virol; 1996 Jun; 49(2):124-31. PubMed ID: 8991935
[TBL] [Abstract][Full Text] [Related]
14. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
[TBL] [Abstract][Full Text] [Related]
15. Adoptive immunotherapy of HCMV infection.
Kapp M; Tan SM; Einsele H; Grigoleit G
Cytotherapy; 2007; 9(8):699-711. PubMed ID: 17917875
[TBL] [Abstract][Full Text] [Related]
16. Effect of serum and CTL on focal growth of human cytomegalovirus.
Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G
J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454
[TBL] [Abstract][Full Text] [Related]
17. Characterization of antigen-specific repertoire diversity following in vitro restimulation by a recombinant adenovirus expressing human cytomegalovirus pp65.
Hamel Y; Rohrlich P; Baron V; Bonhomme D; Rieux-Laucat F; Necker A; Lemonnier F; Ferradini L; Fischer A; Cavazzana-Calvo M
Eur J Immunol; 2003 Mar; 33(3):760-8. PubMed ID: 12616496
[TBL] [Abstract][Full Text] [Related]
18. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation.
Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H
Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.
Borysiewicz LK; Hickling JK; Graham S; Sinclair J; Cranage MP; Smith GL; Sissons JG
J Exp Med; 1988 Sep; 168(3):919-31. PubMed ID: 2844952
[TBL] [Abstract][Full Text] [Related]
20. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
